Αντιγλαυκωματικό φάρμακο σε ασθενείς στους οποίους αντενδείκνυται η χορήγηση κάποιου β-αναστολέως.
Βιβλιογραφική Τεκμηρίωση:
Quantitation of brinzolamide in dried blood spots by a novel LC-QTOF-MS/MS method. Foivas A, Malenović A, Kostić N, Božić M, Knežević M, Loukas YL, Dotsikas Y. J Pharm Biomed Anal. 2015 Nov 28;119:84-90. doi: 10.1016/j.jpba.2015.11.043.
Brinzolamide 1%/timolol versus dorzolamide 2%/timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study. Altafini R, Scherzer ML, Hubatsch DA, Frezzotti P. Clin Ophthalmol. 2015 Dec 1;9:2263-70. doi: 10.2147/OPTH.S88891. eCollection 2015.
Clinical effectiveness of brinzolamide 1%-brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension. Sharma S, Trikha S, Perera SA, Aung T. Clin Ophthalmol. 2015 Nov 24;9:2201-7. doi: 10.2147/OPTH.S72380. eCollection 2015.
brinzolamide (Azopt®)
